Shares of Pennant Group PNTG were flat in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share were up 12.50% year over year to $0.18, which beat the estimate of $0.17.
Revenue of $98,397,000 up by 11.31% year over year, which beat the estimate of $95,810,000.
Outlook
Pennant Sees FY21 Adj. EPS $0.89-$0.99 vs $0.90 Est., Sales $430M-$440M vs $414.53M Est.
Technicals
Company's 52-week high was at $51.27
52-week low: $9.40
Price action over last quarter: Up 26.03%
Company Overview
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health and hospice services which includes our home health, hospice, and home care businesses and Senior living which includes company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The majority of the revenue is generated from the Home Health and Hospice Services segment.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.